Aduro Biotech
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Aduro Biotech sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Aduro Biotech: 7 sponsored US clinical trials, none currently recruiting.
Aduro Biotech sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is 2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer, with 1 trials.
Upper-quartile sponsor footprint
Aduro Biotech sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers
NCT03122548
Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)
NCT03175172
Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer
NCT03189030
Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer
NCT02575807
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
NCT01675765
Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
NCT02004262
Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer
NCT01417000
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
Therapeutic Areas
How the Aduro Biotech early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 3 completed (43%).
Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: 2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Aduro Biotech: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Aduro Biotech sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Aduro Biotech page
7 registered trials is a research-attention snapshot, not an endorsement of Aduro Biotech or any single study.
- None of Aduro Biotech's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- 2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer is the condition Aduro Biotech studies most, compare against other sponsors active in the same condition before evaluating a specific study. See 2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Aduro Biotech pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.